Here, the case of a 17-year-old girl with migraine without aura who developed an ‘Alice in Wonderland’ syndrome repeatedly on topiramate treatment was presented and potential pathophysiological ...
Topiramate is under clinical development by CURx Pharmaceuticals and currently in Phase I for Epilepsy. According to GlobalData, Phase I drugs for Epilepsy have an 84% phase transition success rate ...
Significant difference between controls and topiramate augmentation group (< 0.05) ** Significant difference between controls and topiramate augmentation group (< 0.01) + Significant difference ...
Topiramate is under clinical development by CURx Pharmaceuticals and currently in Phase I for Migraine. According to GlobalData, Phase I drugs for Migraine have an 81% phase transition success rate ...
Topamax (topiramate) is an anti-seizure medication that may be prescribed to prevent certain types of migraine headaches for adults and adolescents age 12 and older. A migraine is more severe than a ...
VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...
Am J Health Syst Pharm. 2008;65(15):1430-1434. Kathryn D. Mathews, PharmD, is Cardiology Clinical Pharmacist, Intermountain Medical Center, Murray, UT; at the time of writing, she was Cardiology ...
The dosage for Topamax (topiramate) may depend on its use. To help prevent migraines, the recommended starting dosage is 25 milligrams (mg) per day. To treat seizures, the typical starting dosage ...